Universally Challenged

Share On Facebook

 

©

Tekcapital (LSE:TEK)  the university IP commerzalisation company,  recently reported interim to the end  of May. For the record a profit of $1.5m was made on unrealised gains from the revaluation of its portfolio, while the revenue from providing services increased by 157% to $635k. Most importantly the business has continued to develop, but  yet the shares remain weak.

The cornerstone of Tek’s proposition is its proprietary discovery search engine linked to 4,000 plus universities in 160 countries. This is coupled with an expert scientific review board providing services for clients to  find and acquire the IP they need to create a competitive advantage. This network can also provide out-licensing firms  IP that can be directly commercialised.

Belluscura Ltd, was set-up by Tekcapital to commercialise and sell proprietary medical devices. It has acquired five products all of which could soon start to produce revenue and it also has licenses for  the IP on 25 medical devices. The intention is to list on the stock market and it recently raised $1.7m pre-ipo at a value of $7.6m; Tek  now owns 48%.

In January 2017, $3m was raised at 35p a share, shareholders include Nigel Wray with 17%, Legal& General 6.7% and the Directors own 21%.  There are currently five major initiatives underway including a salt replacement additive, a food preparation technology that can reduce the fat content  by c. 60%.  Tek have 13 Augmented Reality patents for AR glasses which look like regular glasses but with see-through displays and eye tracking. This  sector is estimated to be worth $83bn bu 2021 and the product development is be accelerated  by  rising upto $10m in AIM’s first issue of a crypto-currency. This crypto currency placing seems to have gone unnoticed and could add significant value to both Tek and the glasses. The prototype development is underway for an in-shoe -energy harvesting device to recharge mobile devices. These technology rights have been acquired for either cash or equity in Tekcapital and present significant up-side potential if /when successfully commercialised.

Financials

The interim net cash was $3.2m with a NAV of $7.9m.

Trading Strategy

After some delays there could be significant upside.

 

Tekcapital (LSE: TEK)

21.5p (20/23p)

Mkt Cap: £9.2m

Next Results:  Year /End October

Last OMG! Price 44p

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191121 11:06:06